INSMED INC Interest Income, Other
INSMED INC (INSM) reported Interest Income, Other of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2025-10-30
- INSMED INC interest income, other for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- INSMED INC interest income, other for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- INSMED INC interest income, other for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- INSMED INC interest income, other for the quarter ending 2024-09-30 was $765.00K, a 14.86% increase year-over-year.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month |
|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-10-30 | $0.00 derived: sum of 2 quarters · filed 2025-10-30 | $0.00 10-Q · filed 2025-10-30 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | ||
| 2024-09-30 | $765.00K 10-Q · filed 2025-10-30 | $1.48M derived: sum of 2 quarters · filed 2025-10-30 | $2.23M 10-Q · filed 2025-10-30 |
| 2024-06-30 | $710.00K 10-Q · filed 2025-08-07 | $1.46M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $754.00K 10-Q · filed 2025-05-08 | ||
| 2023-09-30 | $666.00K 10-Q · filed 2024-10-31 | $1.02M derived: sum of 2 quarters · filed 2024-10-31 | $1.09M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $354.00K 10-Q · filed 2024-08-08 | $427.00K 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $73.00K 10-Q · filed 2024-05-09 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-10-26 | $0.00 derived: sum of 2 quarters · filed 2023-10-26 | $0.00 10-Q · filed 2023-10-26 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |